ANRS, Emerging Infectious Diseases

🇫🇷France

Country: 🇫🇷France

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns

Conditions: Mother to Child HIV Transmission

Interventions: Diagnostic Test: point of care

First Posted Date: 2021-08-24

Last Posted Date: 2022-02-16

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 100

Registration Number: NCT05017558

Partner Notification of Sexually Transmitted Infections (STIs) in Testing Centers

Conditions: Hiv
STI

Interventions: Other: 2 online self-administered questionnaires on

First Posted Date: 2021-06-10

Last Posted Date: 2022-07-25

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 2200

Registration Number: NCT04921618

Locations: 🇫🇷
CeGIDD d'Aix-en-Provence, Aix-en-Provence, France
🇫🇷
CeGIDD - Saint Adrien, Marseille, France
🇫🇷
CeGIDD de Lille, Lille, France

and more 6 locations

Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 Infection

Phase 2

Conditions: Covid19
Covid19 Drug Treatment
SARS-CoV2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2

Interventions: Drug: Nitazoxanide and Ciclésonide
Drug: Telmisartan 20Mg Oral Tablet
Drug: Fluoxétine and Budésonide
Drug: Paracetamol

First Posted Date: 2021-06-10

Last Posted Date: 2023-01-31

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 600

Registration Number: NCT04920838

Locations: 🇬🇳
Centre de traitement des maladies à tendance épidémique de Gbessia, Conakry, Guinea
🇧🇫
Centre Muraz/INSP, Bobo-Dioulasso, Burkina Faso

Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.

Recruiting

Conditions: Papillomavirus Infections
HIV Infections

First Posted Date: 2021-06-02

Last Posted Date: 2022-02-16

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 200

Registration Number: NCT04910438

Locations: 🇹🇬
ONG, Espoir Vie Togo, Lomé, Togo

Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.

Conditions: SARS-CoV Infection
Covid19

Interventions: Other: biobank

First Posted Date: 2021-05-13

Last Posted Date: 2022-04-13

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 2000

Registration Number: NCT04885452

Locations: 🇫🇷
CH Agen-Nerac, Agen, France
🇫🇷
CHU d'Angers, Angers, France
🇫🇷
CHR Metz-Thionville, Ars-Laquenexy, France

and more 34 locations

Protective Measures Against SARS-CoV-2 Contamination of Young Healthy Volunteers During a Concert of Actual Music

Not Applicable

Withdrawn

Conditions: Corona Virus Infection

Interventions: Other: Assisting to the event

First Posted Date: 2021-05-03

Last Posted Date: 2021-12-30

Lead Sponsor: ANRS, Emerging Infectious Diseases

Registration Number: NCT04868942

Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week

Phase 3

Conditions: HIV Infections

Interventions: Drug: ARV bitherapie

First Posted Date: 2021-04-30

Last Posted Date: 2021-11-08

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 440

Registration Number: NCT04867083

Locations: 🇫🇷
Centre hospitalier Victor Dupouy/Service d'Hématologie-Unité d'Immunologie, Argenteuil Cedex, France
🇫🇷
Hôpital Louis Pasteur/Service des Maladies Infectieuses, Chartres, Le Coudray, France
🇫🇷
Centre hospitalier de Poissy/Service des Maladies Infectieuses, Poissy, France

and more 35 locations

Severity of the New UK SARS-Cov2 Variant in COVID-19 Infection

Conditions: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Interventions: Other: Data collection

First Posted Date: 2021-04-28

Last Posted Date: 2021-04-28

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 2200

Registration Number: NCT04863547

Locations: 🇫🇷
CHU Amiens Picardie Site Nord, Amiens, France
🇫🇷
hôpital Avicenne, Bobigny, France
🇫🇷
Centre hospitalier métropole Savoie, Chambéry, France

and more 49 locations

National Survey About Trajectory and Life Conditions of HIV Trans People in France

Completed

Conditions: HIV Seropositivity

Interventions: Other: Questionnaire

First Posted Date: 2021-04-19

Last Posted Date: 2024-02-12

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 536

Registration Number: NCT04849767

Locations: 🇫🇷
INSERM, Marseille, France

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Phase 1

Active, not recruiting

Conditions: Healthy Adults

Interventions: Biological: Drep-HIV-PT1 0.2mg and CN54gp140/MPLA-L
Biological: DREP-HIV-PT1 1mg and CN54gp140/MPLA-L (see above)
Biological: DNA-HIV-PT123 4mg and CN54gp140/MPLA-L

First Posted Date: 2021-04-14

Last Posted Date: 2024-01-03

Lead Sponsor: ANRS, Emerging Infectious Diseases

Target Recruit Count: 68

Registration Number: NCT04844775

Locations: 🇫🇷
Hôpital Henri Mondor, Créteil, Paris, France
🇫🇷
CIC Cochin, Paris, Paris Cedex 14, France
🇨🇭
CHUV, Lausanne, Vaud, Switzerland

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy